CA
DMTK

Clearstead Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Clearstead Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-750
Closed -$465 – 2080
2024
Q1 		$465 Hold
750
– – ﹤0.01% 1461
2023
Q4 		$1.31K Sell
750
-750
-50% -$1.09K ﹤0.01% 1359
2023
Q3 		$2.16K Buy
1,500
+1,100
+275% +$2.75K ﹤0.01% 1393
2023
Q2 		$1.04K Buy
+400
New +$1.2K ﹤0.01% 1243

Other funds holding DMTK

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Clearstead Advisors's DMTK Position: Q2 2024 in Review

Clearstead Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 750 shares — an estimated $465 sold.

Clearstead Advisors first reported a position in DMTK in Q2 2023 and held it in 4 quarters. The position peaked at $2.16K in Q3 2023. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Clearstead Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Clearstead Advisors sold 750 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $465.
  • Clearstead Advisors first reported a position in DermTech, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Clearstead Advisors's DermTech, Inc. Common Stock position peaked at $2.16K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Clearstead Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.